TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia

Pui, 2008, Acute lymphoblastic leukaemia, Lancet, 371, 1030, 10.1016/S0140-6736(08)60457-2 Armstrong, 2005, Molecular genetics of acute lymphoblastic leukemia, J Clin Oncol, 23, 6306, 10.1200/JCO.2005.05.047 Look, 1997, Oncogenic transcription factors in the human acute leukemias, Science, 278, 1059, 10.1126/science.278.5340.1059 Shannon, 1998, Genetic predispositions and childhood cancer, Environ Health Perspect, 106 Suppl 3, 801 Olsen, 1995, Cancer in the parents of children with cancer, N Engl J Med, 333, 1594, 10.1056/NEJM199512143332403 Rudant, 2007, Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE), Int J Cancer, 121, 119, 10.1002/ijc.22624 Lawrence, 2014, Discovery and saturation analysis of cancer genes across 21 tumour types, Nature, 505, 495, 10.1038/nature12912 Alexandrov, 2013, Signatures of mutational processes in human cancer, Nature, 500, 415, 10.1038/nature12477 Mullighan, 2009, Global genomic characterization of acute lymphoblastic leukemia, Semin Hematol, 46, 3, 10.1053/j.seminhematol.2008.09.005 Aifantis, 2008, Molecular pathogenesis of T-cell leukaemia and lymphoma, Nat Rev Immunol, 8, 380, 10.1038/nri2304 Belver, 2016, The genetics and mechanisms of T cell acute lymphoblastic leukaemia, Nat Rev Cancer, 16, 494, 10.1038/nrc.2016.63 Iacobucci, 2017, Genetic basis of acute lymphoblastic leukemia, J Clin Oncol, 35, 975, 10.1200/JCO.2016.70.7836 Ferrando, 2003, Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation, Blood, 102, 262, 10.1182/blood-2002-10-3221 Ferrando, 2002, Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia, Cancer Cell, 1, 75, 10.1016/S1535-6108(02)00018-1 Yeoh, 2002, Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling, Cancer Cell, 1, 133, 10.1016/S1535-6108(02)00032-6 Homminga, 2011, Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia, Cancer Cell, 19, 484, 10.1016/j.ccr.2011.02.008 Weng, 2004, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, 306, 269, 10.1126/science.1102160 Okuda, 1995, Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia, Blood, 85, 2321, 10.1182/blood.V85.9.2321.bloodjournal8592321 Thompson, 2007, The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia, J Exp Med, 204, 1825, 10.1084/jem.20070872 O'Neil, 2007, FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors, J Exp Med, 204, 1813, 10.1084/jem.20070876 Pear, 1996, Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles, J Exp Med, 183, 2283, 10.1084/jem.183.5.2283 Li, 2008, Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1, J Exp Med, 205, 2851, 10.1084/jem.20081561 Palomero, 2006, NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth, Proc Natl Acad Sci U S A, 103, 18261, 10.1073/pnas.0606108103 Sharma, 2006, Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc, Mol Cell Biol, 26, 8022, 10.1128/MCB.01091-06 Weng, 2006, c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma, Genes Dev, 20, 2096, 10.1101/gad.1450406 Sanda, 2010, Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia, Blood, 115, 1735, 10.1182/blood-2009-07-235143 Mullighan, 2007, Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia, Nature, 446, 758, 10.1038/nature05690 Li, 2014, Cyclin C is a haploinsufficient tumour suppressor, Nat Cell Biol, 16, 1080, 10.1038/ncb3046 O'Neil, 2007, Alu elements mediate MYB gene tandem duplication in human T-ALL, J Exp Med, 204, 3059, 10.1084/jem.20071637 Lahortiga, 2007, Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia, Nat Genet, 39, 593, 10.1038/ng2025 Gutierrez, 2011, The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia, Blood, 118, 4169, 10.1182/blood-2010-11-318873 Gutierrez, 2009, High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia, Blood, 114, 647, 10.1182/blood-2009-02-206722 Gutierrez, 2010, Inactivation of LEF1 in T-cell acute lymphoblastic leukemia, Blood, 115, 2845, 10.1182/blood-2009-07-234377 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Comeaux, 2017, TP53 Mutations in hypodiploid acute lymphoblastic leukemia, Cold Spring Harb Perspect Med, 7, a026286, 10.1101/cshperspect.a026286 McCormack, 2004, Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency, N Engl J Med, 350, 913, 10.1056/NEJMra032207 Hacein-Bey-Abina, 2002, Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy, N Engl J Med, 346, 1185, 10.1056/NEJMoa012616 Hacein-Bey-Abina, 2003, A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency, N Engl J Med, 348, 255, 10.1056/NEJM200301163480314 Hacein-Bey-Abina, 2003, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1, Science, 302, 415, 10.1126/science.1088547 Howe, 2008, Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients, J Clin Invest, 118, 3143, 10.1172/JCI35798 Qasim, 2009, Progress and prospects: gene therapy for inherited immunodeficiencies, Gene Ther, 16, 1285, 10.1038/gt.2009.127 O'Neil, 2006, Activating Notch1 mutations in mouse models of T-ALL, Blood, 107, 781, 10.1182/blood-2005-06-2553 Zha, 2010, ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification, J Exp Med, 207, 1369, 10.1084/jem.20100285 Tremblay, 2010, Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes, Genes Dev, 24, 1093, 10.1101/gad.1897910 Eguchi-Ishimae, 2008, NOTCH1 mutation can be an early, prenatal genetic event in T-ALL, Blood, 111, 376, 10.1182/blood-2007-02-074690 Porcher, 2017, SCL/TAL1: a multifaceted regulator from blood development to disease, Blood, 129, 2051, 10.1182/blood-2016-12-754051 Begley, 1989, Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript, Proc Natl Acad Sci U S A, 86, 2031, 10.1073/pnas.86.6.2031 Shivdasani, 1995, Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL, Nature, 373, 432, 10.1038/373432a0 Porcher, 1996, The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages, Cell, 86, 47, 10.1016/S0092-8674(00)80076-8 Drake, 1997, TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis, Dev Biol, 192, 17, 10.1006/dbio.1997.8751 Mouthon, 1993, Expression of tal-1 and GATA-binding proteins during human hematopoiesis, Blood, 81, 647, 10.1182/blood.V81.3.647.647 Herblot, 2000, SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression, Nat Immunol, 1, 138, 10.1038/77819 Mikkola, 2003, Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene, Nature, 421, 547, 10.1038/nature01345 Curtis, 2004, SCL is required for normal function of short-term repopulating hematopoietic stem cells, Blood, 103, 3342, 10.1182/blood-2003-09-3202 Souroullas, 2009, Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival, Cell Stem Cell, 4, 180, 10.1016/j.stem.2009.01.001 Wadman, 1997, The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins, EMBO J, 16, 3145, 10.1093/emboj/16.11.3145 Kassouf, 2010, Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells, Genome Res, 20, 1064, 10.1101/gr.104935.110 Wilson, 2010, Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators, Cell Stem Cell, 7, 532, 10.1016/j.stem.2010.07.016 Palii, 2011, Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages, EMBO J, 30, 494, 10.1038/emboj.2010.342 Porcher, 1999, Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding, Development, 126, 4603, 10.1242/dev.126.20.4603 Kassouf, 2008, Differential use of SCL/TAL-1 DNA-binding domain in developmental hematopoiesis, Blood, 112, 1056, 10.1182/blood-2007-12-128900 El Omari, 2013, Structural basis for LMO2-driven recruitment of the SCL: E47bHLH heterodimer to hematopoietic-specific transcriptional targets, Cell Rep, 4, 135, 10.1016/j.celrep.2013.06.008 Moignard, 2013, Transcriptional hierarchies regulating early blood cell development, Blood Cells Mol Dis, 51, 239, 10.1016/j.bcmd.2013.07.007 Novershtern, 2011, Densely interconnected transcriptional circuits control cell states in human hematopoiesis, Cell, 144, 296, 10.1016/j.cell.2011.01.004 Wilson, 2009, The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development, Blood, 113, 5456, 10.1182/blood-2009-01-200048 Odom, 2006, Core transcriptional regulatory circuitry in human hepatocytes, Mol Syst Biol, 2, 2006.0017, 10.1038/msb4100059 Cole, 2008, Mapping key features of transcriptional regulatory circuitry in embryonic stem cells, Cold Spring Harb Symp Quant Biol, 73, 183, 10.1101/sqb.2008.73.027 Saint-Andre, 2016, Models of human core transcriptional regulatory circuitries, Genome Res, 26, 385, 10.1101/gr.197590.115 Boyer, 2005, Core transcriptional regulatory circuitry in human embryonic stem cells, Cell, 122, 947, 10.1016/j.cell.2005.08.020 Kim, 2008, An extended transcriptional network for pluripotency of embryonic stem cells, Cell, 132, 1049, 10.1016/j.cell.2008.02.039 Loh, 2006, The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells, Nat Genet, 38, 431, 10.1038/ng1760 Batta, 2014, Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells, Cell Rep, 9, 1871, 10.1016/j.celrep.2014.11.002 Whyte, 2013, Master transcription factors and mediator establish super-enhancers at key cell identity genes, Cell, 153, 307, 10.1016/j.cell.2013.03.035 Hnisz, 2013, Super-enhancers in the control of cell identity and disease, Cell, 155, 934, 10.1016/j.cell.2013.09.053 Bernstein, 2010, The NIH Roadmap Epigenomics Mapping Consortium, Nat Biotechnol, 28, 1045, 10.1038/nbt1010-1045 Mansour, 2014, Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element, Science, 346, 1373, 10.1126/science.1259037 Breit, 1993, Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes, J Exp Med, 177, 965, 10.1084/jem.177.4.965 Kelliher, 1996, Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha, EMBO J, 15, 5160, 10.1002/j.1460-2075.1996.tb00900.x Draheim, 2011, A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice, Oncogene, 30, 1252, 10.1038/onc.2010.495 Aplan, 1997, An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice, EMBO J, 16, 2408, 10.1093/emboj/16.9.2408 O'Neil, 2004, TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB, Cancer Cell, 5, 587, 10.1016/j.ccr.2004.05.023 Abraham, 2017, Small genomic insertions form enhancers that misregulate oncogenes, Nat Commun, 8, 14385, 10.1038/ncomms14385 Li, 2017, APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL, Leukemia, 10.1038/leu.2017.75 Rahman, 2017, Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia, Blood, 129, 3221, 10.1182/blood-2016-09-742148 Hsu, 1994, Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells, Proc Natl Acad Sci U S A, 91, 3181, 10.1073/pnas.91.8.3181 Grutz, 1998, The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells, EMBO J, 17, 4594, 10.1093/emboj/17.16.4594 Sanda, 2012, Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia, Cancer Cell, 22, 209, 10.1016/j.ccr.2012.06.007 Kwiatkowski, 2014, Targeting transcription regulation in cancer with a covalent CDK7 inhibitor, Nature, 511, 616, 10.1038/nature13393 Kee, 2009, E and ID proteins branch out, Nat Rev Immunol, 9, 175, 10.1038/nri2507 Murre, 2005, Helix-loop-helix proteins and lymphocyte development, Nat Immunol, 6, 1079, 10.1038/ni1260 Engel, 2001, Early thymocyte development is regulated by modulation of E2A protein activity, J Exp Med, 194, 733, 10.1084/jem.194.6.733 Takeda, 1990, Functional analysis of the murine T-cell receptor beta enhancer and characteristics of its DNA-binding proteins, Mol Cell Biol, 10, 5027 Kee, 1998, Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12, J Exp Med, 188, 699, 10.1084/jem.188.4.699 Schwartz, 2006, Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development, Proc Natl Acad Sci U S A, 103, 9976, 10.1073/pnas.0603728103 Bain, 1997, E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas, Mol Cell Biol, 17, 4782, 10.1128/MCB.17.8.4782 Goldfarb, 1995, Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism, Blood, 85, 465, 10.1182/blood.V85.2.465.465 O'Neil, 2001, The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice, Oncogene, 20, 3897, 10.1038/sj.onc.1204519 Nie, 2003, Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities, EMBO J, 22, 5780, 10.1093/emboj/cdg567 Yui, 2014, Developmental gene networks: a triathlon on the course to T cell identity, Nat Rev Immunol, 14, 529, 10.1038/nri3702 Fasseu, 2007, p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis, Blood, 110, 2610, 10.1182/blood-2007-01-066209 Liau, 2017, Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia, Leukemia, 10.1038/leu.2016.392 Chen, 2009, Zebrafish blood stem cells, J Cell Biochem, 108, 35, 10.1002/jcb.22251 Wang, 2011, Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells, Proc Natl Acad Sci U S A, 108, 14908, 10.1073/pnas.1109023108 Appert, 2009, Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia, Cancer Res, 69, 4784, 10.1158/0008-5472.CAN-08-4774 Tanaka, 2011, Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain, J Biol Chem, 286, 3707, 10.1074/jbc.M110.188193 Chambers, 2015, LMO2 at 25 years: a paradigm of chromosomal translocation proteins, Open Biol, 5, 150062, 10.1098/rsob.150062 Knoechel, 2014, An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia, Nat Genet, 46, 364, 10.1038/ng.2913